scispace - formally typeset
Search or ask a question
Author

Juan Ma

Bio: Juan Ma is an academic researcher from Yanbian University. The author has contributed to research in topics: NF-κB & IκBα. The author has an hindex of 19, co-authored 50 publications receiving 773 citations.

Papers published on a yearly basis

Papers
More filters
Journal ArticleDOI
TL;DR: This study has investigated the antidepressant mechanism of arctigenin by conducting in vitro and in vivo studies, and found that proinflammatory cytokines in microglia via high‐mobility group box 1 (HMGB1)/TLR4/NF‐κB and TNF‐α/TNFR1/NF-κB signalling pathways, leading to depression.
Abstract: Background and purpose Arctigenin, a major bioactive component of Fructus arctii, has been reported to have antidepressant-like effects. However, the mechanisms underlying these effects are still unclear. Neuroinflammation can be caused by excessive production of proinflammatory cytokines in microglia via high-mobility group box 1 (HMGB1)/TLR4/NF-κB and TNF-α/TNFR1/NF-κB signalling pathways, leading to depression. In this study, we have investigated the antidepressant mechanism of arctigenin by conducting in vitro and in vivo studies. Experimental approach The effects of chronic unpredictable mild stress (CUMS) on wild-type (WT) and TLR4-/- mice were examined. Antidepressant-like effects of arctigenin were tested using the CUMS-induced model of depression in WT mice. The effects of arctigenin were assessed on the HMGB1/TLR4/NF-κB and TNF-α/TNFR1/NF-κB signalling pathways in the prefrontal cortex (PFC) of mouse brain and HMGB1- or TNF-α-stimulated primary cultured microglia. The interaction between HMGB1 and TLR4 or TNF-α and TNFR1 with or without arctigenin was examined by localized surface plasmon resonance (LSPR) and co-immunoprecipitation assays. Key results The immobility times in the tail suspension test (TST) and forced swimming test (FST) were reduced in TLR4-/- mice, compared with WT mice. Arctigenin exhibited antidepressant-like effects. Arctigenin also inhibited microglia activation and inflammatory responses in the PFC of mouse brain. Arctigenin inhibited HMGB1 and TLR4 or TNF-α and TNFR1 interactions, and suppressed both HMGB1/TLR4/NF-κB and TNF-α/TNFR1/NF-κB signalling pathways. Conclusions and implications Arctigenin has antidepressant-like effects by attenuating excessive microglial activation and neuroinflammation through the HMGB1/TLR4/NF-κB and TNF-α/TNFR1/NF-κB signalling pathways. This suggests that arctigenin has potential as a new drug candidate suitable for clinical trials to treat depression.

83 citations

Journal ArticleDOI
TL;DR: It is suggested that imperatorin is an effective inhibitor of HIF-1 and provide new perspectives into the mechanism of its anticancer activity.

76 citations

Journal ArticleDOI
TL;DR: The anti-inflammatory effects of artemisinin in TPA-induced skin inflammation in mice were demonstrated and it was proved that art Artemisinin potentiated TNF-α-induced apoptosis.
Abstract: Artemisinin, isolated from the Chinese plant Artemisia annua, has been used for many years to treat different forms of malarial parasites. In this study, we explored the anti-inflammatory activity of artemisinin and the underlying mechanism of this action. We demonstrated that the anti-inflammatory effects of artemisinin in TPA-induced skin inflammation in mice. Then the artemisinin significantly inhibited the expression of NF-κB reporter gene induced by TNF-α in a dose-dependent manner. Artemisinin also inhibited TNF-α induced phosphorylation and degradation of IκBα, p65 nuclear translocation. Artemisinin also has an impact on upstream signaling of IKK through the inhibition of expression of adaptor proteins, TNF receptor-associated factor 2 (TRAF2) and receptor interacting protein 1 (RIP1). Furthermore, pretreatment of cells with artemisinin prevented the TNF-α-induced expression of NF-κB target genes, such as anti-apoptosis (c-IAP1, Bcl-2, and FLIP), proliferation (COX-2, cyclinD1), invasion (MMP-9), angiogenesis (VEGF), and major inflammatory cytokines (TNF-α, iNOS, and MCP1). We also proved that artemisinin potentiated TNF-α-induced apoptosis. Moreover, artemisinin significantly impaired the ROS production and phosphorylation of p38 and ERK, but did not affect the phosphorylation of JNK. Taken together, artemisinin may be a potentially useful therapeutic agent for inflammatory-related diseases.

76 citations

Journal ArticleDOI
TL;DR: Investigation of the potential activity of panaxadiol on programmed cell death-ligand 1 (PD-L1) expression and tumour proliferation in human colon cancer cells and the underlying mechanism revealed insights into development of cancer therapeutic through PD-L 1 inhibition.

57 citations

Journal ArticleDOI
TL;DR: Results indicate that SERT might treat depression by inhibiting the activation of microglia via the NF-κB signaling pathway and provides a basis for the research and development of antidepressants that act to reduce inflammation and the expression of inflammatory mediators.

53 citations


Cited by
More filters
01 Jan 1982
TL;DR: A pesar de los riesgos tan elevados que supone el contraer la toxoplasmosis for estos grupos and de que un individuo se pueda infectar después de una trasfusión sanguínea, ésta no es una enfermedad de declaración obligatoria.
Abstract: OFFARM 123 E reservorio principal de Toxoplasma gondii es el gato doméstico (Felis catus), que por medio de los ooquistes que elimina con las heces, disemina la infección en el medio ambiente pudiendo transmitirla a multitud de animales, al hombre o incluso a pájaros y peces. La infección causada por este parásito pasa, en el hombre sano, casi inadvertida, pero no sucede lo mismo en individuos inmunodeprimidos en los que puede llegar a provocar la muerte. También el contraer la toxoplasmosis durante el embarazo entraña para la mujer, y principalmente para su feto, daños que pueden ser fatales pudiendo ocasionar abortos espontáneos o daños irreversibles en el sistema nervioso central del neonato. A pesar de los riesgos tan elevados que supone el contraer la toxoplasmosis para estos grupos y de que un individuo se pueda infectar después de una trasfusión sanguínea, ésta no es una enfermedad de declaración obligatoria.

533 citations

Journal ArticleDOI
TL;DR: The importance of STAT3 as a potential target for cancer therapy is discussed and novel insights into various classes of existing pharmacological inhibitors of this transcription factor that can be potentially developed as anti-cancer drugs are provided.

223 citations

Journal ArticleDOI
TL;DR: The present review has extended to describe other promising compounds including dihydroartemisinin, ginsenoside Rh2, compound K, cucurbitacins D, E, I, tanshinone IIA and cryptotanshin one in view of their potentials in cancer therapy.
Abstract: Numerous natural products originated from Chinese herbal medicine exhibit anti-cancer activities, including anti-proliferative, pro-apoptotic, anti-metastatic, anti-angiogenic effects, as well as regulate autophagy, reverse multidrug resistance, balance immunity, and enhance chemotherapy in vitro and in vivo. To provide new insights into the critical path ahead, we systemically reviewed the most recent advances (reported since 2011) on the key compounds with anti-cancer effects derived from Chinese herbal medicine (curcumin, epigallocatechin gallate, berberine, artemisinin, ginsenoside Rg3, ursolic acid, silibinin, emodin, triptolide, cucurbitacin B, tanshinone I, oridonin, shikonin, gambogic acid, artesunate, wogonin, β-elemene, and cepharanthine) in scientific databases (PubMed, Web of Science, Medline, Scopus, and Clinical Trials). With a broader perspective, we focused on their recently discovered and/or investigated pharmacological effects, novel mechanism of action, relevant clinical studies, and their innovative applications in combined therapy and immunomodulation. In addition, the present review has extended to describe other promising compounds including dihydroartemisinin, ginsenoside Rh2, compound K, cucurbitacins D, E, I, tanshinone IIA and cryptotanshinone in view of their potentials in cancer therapy. Up to now, the evidence about the immunomodulatory effects and clinical trials of natural anti-cancer compounds from Chinese herbal medicine is very limited, and further research is needed to monitor their immunoregulatory effects and explore their mechanisms of action as modulators of immune checkpoints.

214 citations